PharmaTher Holdings Ltd. (OTC:PHRRF – Get Free Report) shares rose 10.3% during mid-day trading on Thursday . The company traded as high as $0.32 and last traded at $0.32. Approximately 637,740 shares traded hands during trading, an increase of 188% from the average daily volume of 221,608 shares. The stock had previously closed at $0.29.
PharmaTher Stock Performance
The firm has a 50 day moving average of $0.17 and a 200 day moving average of $0.16.
About PharmaTher
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury.
Further Reading
- Five stocks we like better than PharmaTher
- Dividend Payout Ratio Calculator
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- What is Insider Trading? What You Can Learn from Insider Trading
- Is IBM’s AI Transformation Powering a Sustained Rally?
- What Are Some of the Best Large-Cap Stocks to Buy?
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
